Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/16/1999 | US5986048 Process for obtaining insulin precursors having correctly bonded cystine bridges |
11/16/1999 | US5986047 Peptides that bind to the erythropoietin receptor |
11/16/1999 | US5986043 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
11/16/1999 | US5985938 Method for reducing oxalate |
11/16/1999 | US5985891 Use of virginiamycin to control the passage of carbohydrates into the gastrointestinal tract and the fermentation of these carbohydrates therein, controlling the accumulation of acid in the digestive tract |
11/16/1999 | US5985877 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
11/16/1999 | US5985863 Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor |
11/16/1999 | US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar |
11/16/1999 | US5985855 Treatment of global and focal ischemia using NAALADase inhibitors |
11/16/1999 | US5985854 Prodrugs with enhanced penetration into cells |
11/16/1999 | US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof |
11/16/1999 | US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent |
11/16/1999 | US5985839 Treating cancer, psoriasis, acne |
11/16/1999 | US5985837 Cell growth inhibitor peptides; treating cancer in a mammal |
11/16/1999 | US5985835 Desmopressin for nocturia, incontinence and enuresis |
11/16/1999 | US5985834 Nova- and decapeptides in the preparation of a drug for the treatment of aids |
11/16/1999 | US5985833 Thrombin inhibitor |
11/16/1999 | US5985832 Inhibiting osteoclastogenesis by administering osteoclast inhibitor protein (oip) to a cell |
11/16/1999 | US5985830 Use of IGF-I for the treatment of kidney disorders |
11/16/1999 | US5985829 Screening assays for compounds that cause apoptosis and related compounds |
11/16/1999 | US5985828 Screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies |
11/16/1999 | US5985827 Increasing the specificity of a synthetic arg-gly-asp-containing ligand for an arg-gly-asp receptor comprising conformationally restricting the arg-gly-asp sequence by forming a cyclic peptide |
11/16/1999 | US5985825 Methods and compositions for optimization of oxygen transport by cell-free systems |
11/16/1999 | US5985823 Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
11/16/1999 | US5985822 Relates to peptides comprising at least part of the amino acid sequence of neural cell adhesion molecule (n-cam) and to compositions that utilize these peptides to inhibit dna synthesis and cell division of glial cells |
11/16/1999 | US5985664 Antisense modulation of Sentrin expression |
11/16/1999 | US5985663 Antisense inhibition of interleukin-15 expression |
11/16/1999 | US5985662 By incubating hepatitis b virus or incubating cells, tissues, or a bodily fluid which contains hepatitis b virus with an antisense oligonucleotide of given nucleotide sequences under conditions where viral replication is inhibited |
11/16/1999 | US5985661 Human t-lymphocyte transduced in vitro with a vector comprising genes encoding first and second ribozyme moieties, hte first cleaves hiv-1 rna in the tat gene, and second cleaves hiv-1 rna in a common exon for tat and rev genes |
11/16/1999 | US5985657 Nucleotide sequence coding for human il-1; expression vectors and host cells |
11/16/1999 | US5985656 Human cell line comprising, double negative suppressor cells characterized by specific surface marker pattern, which inhibit the mixed lymphocyte reaction in vitro, but do not kill corresponding target cells; density gradient separation |
11/16/1999 | US5985654 Gene which expresses a protein corresponding to the conserved exposed region of the m6 protein, a virulence factor of streptococcus; poxvirus such as vaccinia containing m6 gene used as vaccines against streptococcal infection |
11/16/1999 | US5985640 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
11/16/1999 | US5985635 Nucleic acids encoding novel human serine/threonine protein kinases |
11/16/1999 | US5985633 Human manganese superoxide dismutase proteins |
11/16/1999 | US5985631 Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease |
11/16/1999 | US5985621 Capable of cleaving a rna |
11/16/1999 | US5985620 Polynucleotide |
11/16/1999 | US5985616 Chimeric mammalian NPY Y5 receptors |
11/16/1999 | US5985614 Polynucleotides encoding interleukin-19 |
11/16/1999 | US5985613 Use of an "immunodeficiency-virus suppressing lymphokine (ISL) "to inhibit the replication of viruses, in particular of retroviruses |
11/16/1999 | US5985611 Culturing animal cells; transformation with gene expression; recovering |
11/16/1999 | US5985608 Actin-binding polypeptides and nucleic acids encoding the same |
11/16/1999 | US5985606 Human preprotachykinin B |
11/16/1999 | US5985604 Polynucleotide |
11/16/1999 | US5985601 Isolated polynucleotide |
11/16/1999 | US5985599 Nucleic acid encoding a protein capable of binding to immunoglobulin |
11/16/1999 | US5985598 TCL-1 gene and protein and related methods and compositions |
11/16/1999 | US5985592 Uses for pentoxifylline or functional derivatives/metabolites thereof |
11/16/1999 | US5985589 Dna sequences |
11/16/1999 | US5985586 Methods for identifying compounds that modulate the activity of human N-methyl-D-aspartate receptors |
11/16/1999 | US5985585 Competitive binding; detection |
11/16/1999 | US5985583 Hybridization; measurement signal transduction |
11/16/1999 | US5985564 Inhibitor of chromosome segregation |
11/16/1999 | US5985558 Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos |
11/16/1999 | US5985553 erbB-2 gene segments, probes, recombinant DNA and kits for detection |
11/16/1999 | US5985547 Detection of a mutation in the HLA-DMβ gene in an immunocompromised patient |
11/16/1999 | US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives |
11/16/1999 | US5985332 Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof |
11/16/1999 | US5985331 Methods of use of phthalocyanines to inactivate blood borne parasites |
11/16/1999 | US5985321 Soft gelatin capsule manufacture |
11/16/1999 | US5985320 Drug delivery; medical diagnosis; genetic engineering; administering agent that interacts with cell surface receptors |
11/16/1999 | US5985309 Preparation of particles for inhalation |
11/16/1999 | US5985305 Sustained delivery of an active agent using an implantable system |
11/16/1999 | US5985292 Active phospholipids as a vector for active molecules |
11/16/1999 | US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections |
11/16/1999 | US5985286 Adenyl cyclase-hemolysin (ac-hly) protein, |
11/16/1999 | US5985283 Adenovirus E1A-Associated protein BS69, inhibitor of E1A-transactivation |
11/16/1999 | US5985280 Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor |
11/16/1999 | US5985279 Humanized antibody against CD18 |
11/16/1999 | US5985278 Anti-αV-integrin monoclonal antibody |
11/16/1999 | US5985277 Useful for diagnosis and treatement of corynebacterium infections and diseases. |
11/16/1999 | US5985276 Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies |
11/16/1999 | US5985275 β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection |
11/16/1999 | US5985272 Human myeloperoxidase and its therapeutic application |
11/16/1999 | US5985271 Prophylactic and theraputic treatment of group A streptococcal infection |
11/16/1999 | US5985270 Antitumor |
11/16/1999 | US5985268 Gamma-irradiated bacterial preparation having anti-tumor activity |
11/16/1999 | US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation. |
11/16/1999 | US5985263 Substantially pure histidine-linked protein polymer conjugates |
11/16/1999 | US5985262 Method of treatment with epithelium derived T-cell factor |
11/16/1999 | US5985261 Use of thioredoxin-like molecules for induction of MnSOD to treat oxidative damage |
11/16/1999 | US5985260 Disinfection of blood and biologicals with active albumin-iodine complex |
11/16/1999 | US5985248 Preparing dry powders having hydrophobic and hydrophilic components |
11/16/1999 | US5985242 Peptide of 3 to 5 d-amino acids; may be modified at amino-and/or carboxy terminus; for treatment of amyloidosis, alzheimer's disease |
11/16/1999 | US5985241 Diagnostic and radiodiagnostic agents, formed by reacting technetium-99m with a somatostatin receptor-binding peptide |
11/16/1999 | US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis, |
11/16/1999 | US5984906 Syringe system |
11/16/1999 | CA2088600C Herpes simplex virus vp16 vaccines |
11/16/1999 | CA2078118C Cc-1065 analogs |
11/16/1999 | CA2056402C Therapeutic agent |
11/16/1999 | CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates |
11/16/1999 | CA2031746C Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria |
11/16/1999 | CA1340824C Neurokinin a antagonists |
11/16/1999 | CA1340823C Insulin precursors, process for their preparation and process for the preparation of human insulin |
11/13/1999 | CA2248987A1 Novel compounds |
11/11/1999 | WO1999057565A2 Methods for diagnosing and evaluating cancer |
11/11/1999 | WO1999057320A1 Antisense modulation of cd40 expression |
11/11/1999 | WO1999057303A1 A method for diagnosing and treating chronic pelvic pain syndrome |
11/11/1999 | WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof |